Is PRRVF or MRK a better dividend investment in 2026?

PRRVF currently yields 4651.16% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: PRRVF offers higher current income.

What is the dividend yield difference between PRRVF and MRK?

PRRVF has a forward dividend yield of 4651.16% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 4648.40 percentage points.

Home › Compare › PRRVF vs MRK

PRRVF vs MRK: Dividend Comparison 2026

PRRVF yields 4651.16% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 PRRVF wins by $30843188505348.17M in total portfolio value

INVESTMENT

TIME HORIZON10 years

PRRVF

● Live price

4651.16%

Share price

$0.04

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30843188505348.23M

Annual income

$29,591,646,675,041,542,000.00

Full PRRVF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — PRRVF vs MRK

📍 PRRVF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	PRRVF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, PRRVF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

PRRVF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PRRVF

Annual income on $10K today (after 15% tax)

$395,348.84/yr

After 10yr DRIP, annual income (after tax)

$25,152,899,673,785,310,000.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, PRRVF beats the other by $25,152,899,673,785,303,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PRRVF + MRK for your $10,000?

PRRVF: 50%MRK: 50%

100% MRK50/50100% PRRVF

Portfolio after 10yr

$15421594252674.14M

Annual income

$14,795,823,337,520,775,000.00/yr

Blended yield

95.94%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

PRRVF

No analyst data

Altman Z

-257.9

Piotroski

2/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PRRVF buys

MRK buys

No recent congressional trades found for PRRVF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricPRRVFMRK

Forward yield	4651.16% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$30843188505348.23M ✓	$56.8K
Annual income after 10y	$29,591,646,675,041,542,000.00 ✓	$9,798.13
Total dividends collected	$30758302356405.60M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: PRRVF vs MRK ($10,000, DRIP)

Year	PRRVF Portfolio	PRRVF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$475,816	$465,116.28	$11,206	$366.19	+$464.6K → PRRVF
2	$21,192,291	$20,683,167.97	$12,650	$502.35	+$21.18M → PRRVF
3	$883,613,800	$860,938,048.21	$14,407	$694.19	+$883.60M → PRRVF
4	$34,493,935,088	$33,548,468,322.27	$16,585	$967.82	+$34493.92M → PRRVF
5	$1,260,873,995,359	$1,223,965,484,814.88	$19,342	$1,363.89	+$1260873.98M → PRRVF
6	$43,162,425,070,921	$41,813,289,895,886.25	$22,913	$1,947.19	+$43162425.05M → PRRVF
7	$1,383,902,227,712,904	$1,337,718,432,887,019.00	$27,662	$2,823.89	+$1383902227.69M → PRRVF
8	$41,565,647,713,965,430	$40,084,872,330,312,620.00	$34,159	$4,173.35	+$41565647713.93M → PRRVF
9	$1,169,665,261,968,866,300	$1,125,190,018,914,923,300.00	$43,337	$6,308.80	+$1169665261968.82M → PRRVF
10	$30,843,188,505,348,227,000	$29,591,646,675,041,542,000.00	$56,776	$9,798.13	+$30843188505348.17M → PRRVF

PRRVF vs MRK: Complete Analysis 2026

PRRVF — Stock

Providence Gold Mines Inc., an exploration stage company, engages in the exploration and evaluation of mineral properties located in the United States. The company primarily explores for gold ores. It holds interests in the Providence Mines Property, which includes the Black Oak Mine, Soulsby Mine, Dead Horse Mine, New Albany Mine, Star King Mine, and others located in the Summerville Mining District, Tuolumne County, California. The company was formerly known as Red Hut Metals Inc. and changed its name to Providence Gold Mines Inc. in July 2017. Providence Gold Mines Inc. was incorporated in 2010 and is based in Surrey, Canada.

Full PRRVF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this PRRVF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PRRVF vs SCHD PRRVF vs JEPI PRRVF vs O PRRVF vs KO PRRVF vs MAIN PRRVF vs JNJ PRRVF vs ABBV PRRVF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.